These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

458 related items for PubMed ID: 3095151

  • 1. Antigenic, functional, and molecular genetic studies of human natural killer cells and cytotoxic T lymphocytes not restricted by the major histocompatibility complex.
    Lanier LL, Le AM, Cwirla S, Federspiel N, Phillips JH.
    Fed Proc; 1986 Nov; 45(12):2823-8. PubMed ID: 3095151
    [Abstract] [Full Text] [Related]

  • 2. The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes.
    Lanier LL, Le AM, Civin CI, Loken MR, Phillips JH.
    J Immunol; 1986 Jun 15; 136(12):4480-6. PubMed ID: 3086432
    [Abstract] [Full Text] [Related]

  • 3. Lectin-dependent and anti-CD3 induced cytotoxicity are preferentially mediated by peripheral blood cytotoxic T lymphocytes expressing Leu-7 antigen.
    Phillips JH, Lanier LL.
    J Immunol; 1986 Mar 01; 136(5):1579-85. PubMed ID: 2419407
    [Abstract] [Full Text] [Related]

  • 4. Natural killer (NK)-like cytotoxic activity of allospecific T cell receptor-gamma,delta+ T cell clones. Distinct receptor-ligand interactions mediate NK-like and allospecific cytotoxicity.
    Koide J, Rivas A, Engleman EG.
    J Immunol; 1989 Jun 15; 142(12):4161-8. PubMed ID: 2470816
    [Abstract] [Full Text] [Related]

  • 5. Interleukin-2- and mitogen-activated NK-like killer cells from highly purified human peripheral blood T cell (CD3+ N901-) cultures.
    Atzpodien J, Wisniewski D, Gulati S, Welte K, Knowles R, Clarkson B.
    Nat Immun Cell Growth Regul; 1987 Jun 15; 6(3):129-40. PubMed ID: 3114621
    [Abstract] [Full Text] [Related]

  • 6. Lysis of tumor cells by CD3+4-8-16+ T cell receptor alpha beta- clones, regulated via CD3 and CD16 activation sites, recombinant interleukin 2, and interferon beta 1.
    van de Griend RJ, Tax WJ, van Krimpen BA, Vreugdenhil RJ, Ronteltap CP, Bolhuis RL.
    J Immunol; 1987 Mar 01; 138(5):1627-33. PubMed ID: 2949018
    [Abstract] [Full Text] [Related]

  • 7. Bacterial activation of human natural killer cells. Characteristics of the activation process and identification of the effector cell.
    Tarkkanen J, Saksela E, Lanier LL.
    J Immunol; 1986 Oct 15; 137(8):2428-33. PubMed ID: 3093576
    [Abstract] [Full Text] [Related]

  • 8. Patterns of T cell receptor gamma gene rearrangements in human CD3+ clones derived from WT31- or Leu7+ cells in relation to non-MHC-restricted cytotoxic activity.
    Christmas SE.
    Nat Immun Cell Growth Regul; 1989 Oct 15; 8(6):301-12. PubMed ID: 2560141
    [Abstract] [Full Text] [Related]

  • 9. Major histocompatibility complex-unrestricted cytolytic activity of human T cells. Analysis of precursor frequency and effector phenotype.
    Patel SS, Thiele DL, Lipsky PE.
    J Immunol; 1987 Dec 01; 139(11):3886-95. PubMed ID: 3500232
    [Abstract] [Full Text] [Related]

  • 10. Mode of in vitro augmentation of natural killer cell activity by recombinant human interleukin 2: a comparative study of Leu-11+ and Leu-11- cell populations in cord blood and adult peripheral blood.
    Seki H, Ueno Y, Taga K, Matsuda A, Miyawaki T, Taniguchi N.
    J Immunol; 1985 Oct 01; 135(4):2351-6. PubMed ID: 3928745
    [Abstract] [Full Text] [Related]

  • 11. Expression of Leu-19 (NKH-1) antigen on IL 2-dependent cytotoxic and non-cytotoxic T cell lines.
    Lanier LL, Le AM, Ding A, Evans EL, Krensky AM, Clayberger C, Phillips JH.
    J Immunol; 1987 Apr 01; 138(7):2019-23. PubMed ID: 2951430
    [Abstract] [Full Text] [Related]

  • 12. Recombinant interleukin 2 enhanced natural killer cell-mediated cytotoxicity in human lymphocyte subpopulations expressing the Leu 7 and Leu 11 antigens.
    Lanier LL, Benike CJ, Phillips JH, Engleman EG.
    J Immunol; 1985 Feb 01; 134(2):794-801. PubMed ID: 3871216
    [Abstract] [Full Text] [Related]

  • 13. Leu-Leu-OMe sensitivity of human activated killer cells: delineation of a distinct class of cytotoxic T lymphocytes capable of lysing tumor targets.
    Thiele DL, Lipsky PE.
    J Immunol; 1986 Aug 15; 137(4):1399-406. PubMed ID: 3488348
    [Abstract] [Full Text] [Related]

  • 14. Fc gamma RIII activation is different in CD16+ cytotoxic T lymphocytes and natural killer cells.
    Uciechowski P, Gessner JE, Schindler R, Schmidt RE.
    Eur J Immunol; 1992 Jun 15; 22(6):1635-8. PubMed ID: 1376268
    [Abstract] [Full Text] [Related]

  • 15. Cellular mechanisms of lymphocyte-mediated lysis of tumor cells.
    Arancia G, Malorni W, Donelli G.
    Ann Ist Super Sanita; 1990 Jun 15; 26(3-4):369-84. PubMed ID: 2151107
    [Abstract] [Full Text] [Related]

  • 16. Differences in surface phenotype between cytolytic and non-cytolytic CD4+ T cells. MHC class II-specific cytotoxic T lymphocytes lack Leu 8 antigen and express CD2 in high density.
    Takada S, Koide J, Engleman EG.
    J Immunol; 1989 May 01; 142(9):3038-44. PubMed ID: 2468710
    [Abstract] [Full Text] [Related]

  • 17. Induction and blocking of cytolysis in CD2+, CD3- NK and CD2+, CD3+ cytotoxic T lymphocytes via CD2 50 KD sheep erythrocyte receptor.
    Bolhuis RL, Roozemond RC, van de Griend RJ.
    J Immunol; 1986 Jun 01; 136(11):3939-44. PubMed ID: 3084649
    [Abstract] [Full Text] [Related]

  • 18. Lysis of human solid tumor cells by lymphokine-activated natural killer cells.
    Itoh K, Tilden AB, Balch CM.
    J Immunol; 1986 May 15; 136(10):3910-5. PubMed ID: 3084648
    [Abstract] [Full Text] [Related]

  • 19. Acquisition of non-MHC restricted cytotoxic function by IL 2 activated thymocytes with an "immature" antigenic phenotype.
    Phillips JH, Lanier LL.
    J Immunol; 1987 Aug 01; 139(3):683-7. PubMed ID: 3110279
    [Abstract] [Full Text] [Related]

  • 20. Perforin expression can define CD8 positive lymphocyte subsets in pigs allowing phenotypic and functional analysis of natural killer, cytotoxic T, natural killer T and MHC un-restricted cytotoxic T-cells.
    Denyer MS, Wileman TE, Stirling CM, Zuber B, Takamatsu HH.
    Vet Immunol Immunopathol; 2006 Apr 15; 110(3-4):279-92. PubMed ID: 16325923
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.